16/11/2022 - Press release
A study led by the Hospital del Mar Medical Research Institute, the Barcelonaβeta Brain Research Centre (BBRC), a research unit from the Pasqual Maragall Foundation, and the University of Gothenburg, has compared the validity of nine biomarkers for the day-to-day diagnosis of Alzheimer's disease in hospital centres. The work involved a cohort of patients from Hospital del Mar with various neurological pathologies. The researchers analysed the presence of nine variants of the Tau protein in blood samples from these people. Some of these blood markers are just as useful for detecting Alzheimer's as those measured in the reference test used, namely the analysis of cerebrospinal fluid obtained by lumbar puncture. Less invasive plasma biomarker determinations than those performed after a lumbar puncture may provide a tool for improving the diagnosis of Alzheimer's disease and determining which individuals should undergo further testing to confirm the diagnosis. The work has been published in the leading journal in this field, Alzheimer's & Dementia.
03/11/2022 - Press release
A study led by researchers at the Hospital del Mar Medical Research Institute links psychological trauma in childhood with an increased risk of developing some kind of mental disorder years later. This is the first study to analyse the relationship between psychological trauma and various mental pathologies at a transdiagnostic level. It examines fourteen already published reviews or meta-analyses, involving more than 90,000 participants. The study is published in the European Archives of Psychiatry and Clinical Neuroscience and demonstrates the need to study the history of patients suffering from a mental disorder.
02/11/2022 - General information
The researcher of the Neuroscience Research Program at the Hospital del Mar Medical Research Institute talks in this book with Montserrat Pedreira, PhD in Education and Early Childhood Education teacher, about how we communicate, what makes us curious and how we explore the world. Beatriz Fagundo, PhD in Neuroscience and researcher at the Neuroscience Research Program at IMIM-Hospital del Mar, is one of the authors of Diàlegs entre educació i neurociència, a book that explores the common ground between Neuroscience and Education through a dialogue between the researcher and Montserrat Pedreira, PhD in Education and Early Childhood and Primary Education teacher. The book is published by Eumo Editorial.
Més informació "Diàlegs entre educació i neurociència, the new book of Beatriz Fagundo"
24/10/2022 - General information
The principal investigator of the Research Group on Cell-type mechanisms in normal and pathological behavior at the Hospital del Mar Medical Research Institute received this award at the IACM congress held in Switzerland. Every two years, the International Association for Cannabinoid Medicines (IACM) awards different categories of prizes to researchers working in the field of cannabinoids. This year, the selection committee of this international association has decided to award the Young Investigator Award for research in the field of cannabinoids to Dr. Arnau Busquets, principal investigator of the Research Group on Cell-type mechanisms in normal and pathological behavior at the Hospital del Mar Medical Research Institute (IMIM).
Més informació "IACM Young Investigator Award for Dr. Arnau Busquets"
11/08/2022 - Press release
The research, led by the Barcelonaβeta Brain Research Center (BBRC), research center of the Pasqual Maragall Foundation, the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the University of Gothenburg, has been published in the prestigious journal Nature Medicine. The study, which used data from almost 400 participants of the ALFA+ Study, which has the impetus of the "la Caixa" Foundation, determines that the biomarkers p-tau231 and p-tau217 measured in the blood are suitable for indicating brain changes related to the amyloid protein in people without cognitive symptoms. The results of this research make p-tau231 a very promising blood biomarker to detect early those middle-aged people who show the first brain changes associated with Alzheimer's and to conduct clinical trials aimed at this early stage of Alzheimer's.
26/07/2022 - General information
This is the question that Dr. Daniel Guinart, Dr. Víctor Pérez and Dr. Benedikt Amann, researchers from the Neurosciences Research Programme at the Hospital del Mar Medical Research Institute, attempt to answer in a letter recently published in The Lancet. The role peer reviewers of scientific articles play and the debate on whether their work should be remunerated are the focus of a letter by Dr. Daniel Guinart, Dr. Víctor Pérez and Dr. Benedikt Amann, researchers from the Hospital del Mar Medical Research Institute's Neurosciences Research Programme (IMIM-Hospital del Mar) that has been published in The Lancet. It is a voluntary task, based on a "code of honour", as the authors put it, but which in recent times has become an exploitative system.
Més informació "Should reviewers of scientific journal articles be paid a wage?"
25/07/2022 - Institutional news
Monday 25 July marks the 30th anniversary of the inauguration of the Barcelona Olympic Games, which represented a historic milestone for the city. During this great event, the Anti-Doping Laboratory of the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) was entrusted with the anti-doping controls of the athletes at both the Barcelona 92 Olympic and Paralympic Games. The laboratory was set up in 1985 as part of the Barcelona Olympic bid. Its designation as an Olympic laboratory allowed the modernization of the facilities and equipment of both the laboratory itself and the IMIM. The laboratory took up anarea of 1100 m2, and during the Games it worked 24 hours a day. In total, close to 110 people were involved in the anti-doping work, considering the laboratory staff, guest scientific staff, volunteers and support staff.
Més informació "30 years of the Olympic Anti-Doping Laboratory"
14/07/2022 - General information
After the success of "La mare de la ciència", the PRBB's science outreach podcast in Catalan, June saw the launch of "Absolutos y Relativos", the second science outreach podcast from the PRBB, which this time will be in Spanish. On 14 July, Patricia Robledo, a researcher from the Integrated Pharmacology and Systems Neuroscience research group at the IMIM, explains the neuroscience and drug studies she is carrying out, and talks about her research career, which is closely linked to psychology.
13/05/2022 - General information
A platform developed by the Centre Nacional d'Anàlisi Genòmica (CNAG-CRG) allows doctors and researchers from Catalan hospitals to share data and otherwise scattered expertise and diagnose patients with neurologic rare diseases. During the pilot project, a diagnosis was provided to 67 out of 323 patients (20.7% of cases), just by reanalysing previously available data. The results constitute an important milestone for ending the 'diagnostic odyssey' faced by patients in Catalonia. The collaborative approach also resulted in the identification of six new genes linked to specific diseases, which will make it easier to diagnose certain diseases in the future. The results, published today in The Journal of Molecular Diagnostics, were possible thanks to the Undiagnosed Rare Disease Program of Catalonia (URD-Cat), funded by the Departament de Salut de la Generalitat de Catalunya. The URD-Cat project was coordinated by the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and involved more than 140 professionals from 15 different research centres and hospitals.
Més informació "Catalan collaboration helps end ‘diagnostic odyssey’ for rare disease patients"
19/04/2022 - General information
The VALAWAI project, led by the CSIC with the participation of the Hospital del Mar Medical Research Institute and the Hospital del Mar, has received nearly four million euros from the European Innovation Council under the Pathfinder Challenges. A team from the Neuroimaging of Mental Disorders Research Group at the Hospital del Mar Medical Research Institute, led by Dr. Òscar Vilarroya, along with the Innovation Directorate of the Hospital del Mar, headed by Dr. Jordi Martínez, is part of the VALAWAI project (Value-Aware Artificial Intelligence). The project has recently been granted European funding of nearly four million euros. Its objective is to develop a set of tools for creating artificial intelligence systems that incorporate mechanisms sensitive to human values. In other words, these systems should be capable of deciding whether certain actions are morally acceptable and be aware of their users' value systems.
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
